Skip to content

Preoperative Exercise in Patients Undergoing Total Hip or Knee Replacement

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01003756
Enrollment
165
Registered
2009-10-29
Start date
2009-11-30
Completion date
2011-08-31
Last updated
2012-02-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoarthritis

Keywords

Preoperative, Exercise, Joint Replacement, Hip, Knee

Brief summary

This study is conducted in the Community Hospital in Svendborg (OUH Svendborg Sygehus) in collaboration with University of Southern Denmark and Odense University Hospital. The overall purpose of this study is to evaluate the effects of preoperatively delivered neuromuscular exercise on self perceived physical function, pain and Quality of Life in patients undergoing total hip or knee replacement. Secondary area of interest is physical performance, muscle function, and level of physical activity. The project will be conducted in two phases: * A pilot project focusing on the logistics of the upcoming randomized controlled trial (RCT) and determination of test-retest reliability of specific muscle strength variables for the patients of interest * A randomized and controlled trial where the intervention is preoperative neuromuscular exercise and the controls receive standard instructions.

Interventions

OTHERPreoperative neuromuscular exercise

A neuromuscular exercise programme delivered 8-10 weeks preoperatively. The programme is developed in Lund, Sweden. A journal of this study is under peer-review

Sponsors

Odense University Hospital
CollaboratorOTHER
University of Southern Denmark
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients scheduled for elective primary, unilateral total hip or knee replacement in Svendborg Community Hospital, Odense University Hospital, Denmark. * Patients with osteoarthritis * Age over 18

Exclusion criteria

* Not being able to read and understand Danish. * Patients with co-morbidity diseases where a moderate level of physical exercise is contraindicated, e.g. severe heart disease and neurological deficits. * Patients unable to attend intervention. * Rheumatoid arthritis (RA). A history of or ongoing use of medication for RA or other inflammatory arthritis such as gold, methotrexate, plaquenil etc. * Lack of wish to participate or unwillingness to sign an informed consent. * Specific for hip patients: a history of severe sequelae due to congenital hip-dysplasia requiring specialized postoperative training. A history of femoral neck and trochanteric fracture. * Patients planned to have bilateral joint replacement within same procedure.

Design outcomes

Primary

MeasureTime frameDescription
Change in self reported physical function. Assessed with KOOS/HOOS questionnaire subscale ADL Function3 month postoperative (primary endpoint)Further assessments: baseline, preoperative, 6 weeks postoperative and 1-year follow up

Secondary

MeasureTime frame
Self reported pain. Assessed with KOOS and HOOS subscale on pain.baseline, one week preop., 3 month postop.(primary endpoint) and a 1 year follow up
Self reported quality of life (Qol). Assessed with KOOS and HOOS sub scale quality of lifebaseline, one week preop., 3 month postop.(primary endpoint) and a 1 year follow up
Self reported quality of life. Assessed with EQ5D questionnairebaseline, one week preop., 3 month postop.(primary endpoint) and a 1 year follow up
Observed physical function. Assessed with performance measures: 20 meter walk, 5 chair stands timed and one leg knee bendings/30 secbaseline, one week preop. and 3 month postop.
Muscle strength estimated as average muscle power for muscles of the hip and kneebaseline, 1 week preop. and 3 month postop

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 23, 2026